M Heller
Impact in
- Oncology top 2%
- Viral-associated cancers and disorders
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 19
- Viral-associated cancers and disorders 18
- Epidemiology 10
- Cytomegalovirus and herpesvirus research 10
- Herpesvirus Infections and Treatments 5
- Co-authors
- Elliott Kieff (15 shared papers)T Dambaugh (6 shared papers)Vicky L. van Santen (4 shared papers)A. Henderson (2 shared papers)E Kieff (2 shared papers)W King (5 shared papers)Stuart Rudikoff (5 shared papers)Susumu Tonegawa (2 shared papers)
- Journals
- Journal of Virology (6 papers)Proceedings of the National Academy of Sciences (4 papers)The Journal of Experimental Medicine (2 papers)Molecular and Cellular Biology (2 papers)The Journal of Infectious Diseases (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
M Heller
31 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 75
- Oncology 1.1k
- Pathology and Forensic Medicine 496
- Infectious Diseases 518
- Immunology 485
- Epidemiology 564
Countries citing papers authored by M Heller
This map shows the geographic impact of M Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Heller more than expected).
Fields of papers citing papers by M Heller
This network shows the impact of papers produced by M Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Heller. The network helps show where M Heller may publish in the future.
Co-authors
The 25 scholars most cited alongside M Heller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1980 | 197 | |
| 2 | 1985 | 165 | |
| 3 | 1984 | 142 | |
| 4 | 1981 | 133 | |
| 5 | 1983 | 130 | |
| 6 | 1983 | 121 | |
| 7 | 1984 | 89 | |
| 8 | 2002 | 89 | |
| 9 | 1982 | 85 | |
| 10 | 1982 | 76 | |
| 11 | 1987 | 76 | |
| 12 | 1982 | 76 | |
| 13 | 1982 | 67 | |
| 14 | 2003 | 50 | |
| 15 | 1981 | 44 | |
| 16 | 1981 | 43 | |
| 17 | 1985 | 43 | |
| 18 | 1987 | 38 | |
| 19 | 1982 | 37 | |
| 20 | 1980 | 29 |
About M Heller
M Heller is a scholar working on Oncology, Epidemiology, Immunology, Infectious Diseases and Molecular Biology, having authored 31 papers that have together received 1.9k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (18 papers), Cytomegalovirus and herpesvirus research (10 papers), Parvovirus B19 Infection Studies (8 papers), Lymphoma Diagnosis and Treatment (7 papers), T-cell and B-cell Immunology (6 papers), Herpesvirus Infections and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Oncology (1.1k citations), Pathology and Forensic Medicine (496 citations), Infectious Diseases (518 citations), Immunology (485 citations) and Epidemiology (564 citations). M Heller has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Elliott Kieff, T Dambaugh, Vicky L. van Santen, A. Henderson, E Kieff, W King, Stuart Rudikoff, Susumu Tonegawa, Mary Hummel and Susan M. Fennewald. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine, Molecular and Cellular Biology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.